Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.

Al-Khadairi G, Naik A, Thomas R, Al-Sulaiti B, Rizly S, Decock J.

J Transl Med. 2019 Jan 3;17(1):9. doi: 10.1186/s12967-018-1757-3.

2.

Search for γ-Ray Line Signals from Dark Matter Annihilations in the Inner Galactic Halo from 10 Years of Observations with H.E.S.S.

Abdallah H, Abramowski A, Aharonian F, Ait Benkhali F, Angüner EO, Arakawa M, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bonnefoy S, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Büchele M, Bulik T, Capasso M, Caroff S, Carosi A, Carr J, Casanova S, Cerruti M, Chakraborty N, Chaves RCG, Chen A, Chevalier J, Colafrancesco S, Condon B, Conrad J, Davids ID, Decock J, Deil C, Devin J, deWilt P, Dirson L, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dutson K, Dyks J, Edwards T, Egberts K, Eger P, Emery G, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gallant YA, Garrigoux T, Gaté F, Giavitto G, Giebels B, Glawion D, Glicenstein JF, Gottschall D, Grondin MH, Hahn J, Haupt M, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hofmann W, Hoischen C, Holch TL, Holler M, Horns D, Ivascenko A, Iwasaki H, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katsuragawa M, Katz U, Kerszberg D, Khangulyan D, Khélifi B, King J, Klepser S, Klochkov D, Kluźniak W, Komin N, Kosack K, Krakau S, Kraus M, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Liu R, Lohse T, Lorentz M, López-Coto R, Lypova I, Malyshev D, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Meyer M, Mitchell AMW, Moderski R, Mohamed M, Mohrmann L, Morå K, Moulin E, Murach T, Nakashima S, de Naurois M, Ndiyavala H, Niederwanger F, Niemiec J, Oakes L, O'Brien P, Odaka H, Ohm S, Ostrowski M, Oya I, Padovani M, Panter M, Parsons RD, Pekeur NW, Pelletier G, Perennes C, Petrucci PO, Peyaud B, Piel Q, Pita S, Poireau V, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Rauth R, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Rinchiuso L, Romoli C, Rowell G, Rudak B, Rulten CB, Sahakian V, Saito S, Sanchez DA, Santangelo A, Sasaki M, Schandri M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Seglar-Arroyo M, Settimo M, Seyffert AS, Shafi N, Shilon I, Shiningayamwe K, Simoni R, Sol H, Spanier F, Spir-Jacob M, Stawarz Ł, Steenkamp R, Stegmann C, Steppa C, Sushch I, Takahashi T, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tibaldo L, Tiziani D, Tluczykont M, Trichard C, Tsirou M, Tsuji N, Tuffs R, Uchiyama Y, van der Walt J, van Eldik C, van Rensburg C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zaborov D, Zacharias M, Zanin R, Zdziarski AA, Zech A, Zefi F, Ziegler A, Zorn J, Żywucka N; H.E.S.S. Collaboration.

Phys Rev Lett. 2018 May 18;120(20):201101. doi: 10.1103/PhysRevLett.120.201101.

PMID:
29864326
3.

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.

Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J.

Front Immunol. 2018 May 1;9:947. doi: 10.3389/fimmu.2018.00947. eCollection 2018. Review.

4.

A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification.

Roelands J, Decock J, Boughorbel S, Rinchai D, Maccalli C, Ceccarelli M, Black M, Print C, Chou J, Presnell S, Quinn C, Jithesh P, Syed N, Al Bader SBJ, Bedri S, Wang E, Marincola FM, Chaussabel D, Kuppen P, Miller LD, Bedognetti D, Hendrickx W.

Version 2. F1000Res. 2017 Mar 20 [revised 2018 Jan 1];6:296. doi: 10.12688/f1000research.10960.2. eCollection 2017.

5.

In situ photo-patterning of pressure-resistant hydrogel membranes with controlled permeabilities in PEGDA microfluidic channels.

Decock J, Schlenk M, Salmon JB.

Lab Chip. 2018 Mar 27;18(7):1075-1083. doi: 10.1039/c7lc01342f.

PMID:
29488541
6.

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.

Roelands J, Kuppen PJK, Vermeulen L, Maccalli C, Decock J, Wang E, Marincola FM, Bedognetti D, Hendrickx W.

Int J Mol Sci. 2017 Oct 24;18(10). pii: E2229. doi: 10.3390/ijms18102229. Review.

7.

Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.

Sarper M, Allen MD, Gomm J, Haywood L, Decock J, Thirkettle S, Ustaoglu A, Sarker SJ, Marshall J, Edwards DR, Jones JL.

Breast Cancer Res. 2017 Mar 23;19(1):33. doi: 10.1186/s13058-017-0822-9.

8.

Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, Raulet DH, Weinberg RA.

Cancer Discov. 2016 Jun;6(6):630-49. doi: 10.1158/2159-8290.CD-15-1157. Epub 2016 Apr 12.

9.

Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.

Decock J, Hendrickx W, Thirkettle S, Gutiérrez-Fernández A, Robinson SD, Edwards DR.

Breast Cancer Res. 2015 Mar 14;17:38. doi: 10.1186/s13058-015-0545-8.

10.

Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.

Kelwick R, Wagstaff L, Decock J, Roghi C, Cooley LS, Robinson SD, Arnold H, Gavrilović J, Jaworski DM, Yamamoto K, Nagase H, Seubert B, Krüger A, Edwards DR.

Int J Cancer. 2015 Feb 15;136(4):E14-26. doi: 10.1002/ijc.29129. Epub 2014 Aug 18.

11.

Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.

Hendrickx W, Decock J, Mulholland F, Bao Y, Fairweather-Tait S.

Front Oncol. 2013 Sep 23;3:239. doi: 10.3389/fonc.2013.00239. eCollection 2013.

12.

Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells.

Thirkettle S, Decock J, Arnold H, Pennington CJ, Jaworski DM, Edwards DR.

J Biol Chem. 2013 Jun 7;288(23):16282-94. doi: 10.1074/jbc.M113.464230. Epub 2013 Apr 30.

13.

TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2.

Leivonen SK, Lazaridis K, Decock J, Chantry A, Edwards DR, Kähäri VM.

PLoS One. 2013;8(2):e57474. doi: 10.1371/journal.pone.0057474. Epub 2013 Feb 28.

14.

Matrix metalloproteinases: protective roles in cancer.

Decock J, Thirkettle S, Wagstaff L, Edwards DR.

J Cell Mol Med. 2011 Jun;15(6):1254-65. doi: 10.1111/j.1582-4934.2011.01302.x. Review.

15.

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi.

Van Belle V, Decock J, Hendrickx W, Brouckaert O, Pintens S, Moerman P, Wildiers H, Paridaens R, Christiaens MR, Van Huffel S, Neven P.

Patholog Res Int. 2010 Dec 28;2011:918408. doi: 10.4061/2011/918408.

16.

The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis.

Wagstaff L, Kelwick R, Decock J, Edwards DR.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1861-72. Review.

PMID:
21196270
17.

Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.

Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J.

Int J Biol Markers. 2008 Jul-Sep;23(3):161-8.

PMID:
18949742
18.

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.

Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 May;115(2):349-58. doi: 10.1007/s10549-008-0110-6. Epub 2008 Jul 16.

PMID:
18629635
19.

Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis.

Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R.

BMC Cancer. 2008 Mar 20;8:77. doi: 10.1186/1471-2407-8-77.

20.

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.

Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 Jan;113(1):181-7. doi: 10.1007/s10549-008-9914-7. Epub 2008 Feb 9.

PMID:
18264760
21.

Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.

Decock J, Paridaens R, Ye S.

Clin Genet. 2008 Mar;73(3):197-211. doi: 10.1111/j.1399-0004.2007.00946.x. Epub 2007 Dec 29. Review.

PMID:
18177467
22.

Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.

Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, Ye S.

Cancer Res. 2007 Nov 1;67(21):10214-21.

23.

Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.

Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, Van Limbergen E, Weltens C, Van den Bogaert W, Smeets A, Vergote I, Christiaens MR, Drijkoningen M.

Breast Cancer Res Treat. 2008 Jul;110(1):153-9. Epub 2007 Aug 9.

PMID:
17687649
24.

Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.

Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, Paridaens R.

Dis Markers. 2007;23(3):189-96.

25.

Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.

De Brakeleer S, Bogdani M, De Grève J, Decock J, Sermijn E, Bonduelle M, Goelen G, Teugels E.

Mutat Res. 2007 Jun 1;619(1-2):104-12. Epub 2007 Mar 12.

PMID:
17445839
26.
27.

Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.

Decock J, Hendrickx W, Wildiers H, Christiaens MR, Neven P, Drijkoningen M, Paridaens R.

Clin Exp Metastasis. 2005;22(6):495-502.

PMID:
16320112
28.

Proteases and metastasis: clinical relevance nowadays?

Decock J, Paridaens R, Cufer T.

Curr Opin Oncol. 2005 Nov;17(6):545-50. Review.

PMID:
16224231
30.

Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes.

Decock JB, Gillespie-Brown J, Parker PJ, Sugden PH, Fuller SJ.

FEBS Lett. 1994 Dec 19;356(2-3):275-8.

31.

Sialic acid and neuraminidase after whole body irradiation of rats.

Kocmierska-Grodzka D, Gerber GB, Decock JP.

Acta Radiol Ther Phys Biol. 1974 Feb;13(1):57-64. No abstract available.

PMID:
4826857
32.

Metabolism of deoxycytidine in different organs of mice and rats.

Gerber GB, Deroo J, Decock JP.

Arch Int Physiol Biochim. 1972 Apr;80(2):353-65. No abstract available.

PMID:
4114883

Supplemental Content

Loading ...
Support Center